Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mizon

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Laboratory and Clinical Medicine|March 1, 2000
Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsisM Balduyck, D Albani, M Jourdain, et al.
Vox Sanguinis|January 1, 1994
Preparation and properties of a therapeutic inter-alpha-trypsin inhibitor concentrate from human plasmaC Michalski, F Piva, M Balduyck, et al.
Annals of Clinical Biochemistry|July 1, 1992
A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's diseaseJ el Yamani, B Soudan, C Mizon, et al.
Biological Chemistry Hoppe-Seyler|September 1, 1993
Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI)M Balduyck, F Piva, C Mizon, et al.
Clinical Science (London, England : 1979)|October 1, 1992
Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's diseaseJ el Yamani, C Mizon, C Capon, et al.
Presse Medicale (Paris, France : 1983)|February 27, 1988
[Clinical value of the determination of urinary antitrypsin activity]D Gosset, C Mizon, P Savinel, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulationM Jourdain, O Carrette, A Tournoys, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy]J F Colombel, C Mizon, N Chekkouri, et al.
Clinical Science (London, England : 1979)|May 1, 1991
Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease)C Mizon, J el Yamani, J F Colombel, et al.
Biological Chemistry Hoppe-Seyler|October 1, 1992
The heavy chains of human plasma inter-alpha-trypsin inhibitor: their isolation, their identification by electrophoresis and partial sequencing. Differential reactivity with concanavalin AN Malki, M Balduyck, P Maes, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Laboratory and Clinical Medicine|March 1, 2000
Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsisM Balduyck, D Albani, M Jourdain, et al.
Vox Sanguinis|January 1, 1994
Preparation and properties of a therapeutic inter-alpha-trypsin inhibitor concentrate from human plasmaC Michalski, F Piva, M Balduyck, et al.
Annals of Clinical Biochemistry|July 1, 1992
A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's diseaseJ el Yamani, B Soudan, C Mizon, et al.
Biological Chemistry Hoppe-Seyler|September 1, 1993
Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI)M Balduyck, F Piva, C Mizon, et al.
Clinical Science (London, England : 1979)|October 1, 1992
Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's diseaseJ el Yamani, C Mizon, C Capon, et al.
Presse Medicale (Paris, France : 1983)|February 27, 1988
[Clinical value of the determination of urinary antitrypsin activity]D Gosset, C Mizon, P Savinel, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulationM Jourdain, O Carrette, A Tournoys, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy]J F Colombel, C Mizon, N Chekkouri, et al.
Clinical Science (London, England : 1979)|May 1, 1991
Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease)C Mizon, J el Yamani, J F Colombel, et al.
Biological Chemistry Hoppe-Seyler|October 1, 1992
The heavy chains of human plasma inter-alpha-trypsin inhibitor: their isolation, their identification by electrophoresis and partial sequencing. Differential reactivity with concanavalin AN Malki, M Balduyck, P Maes, et al.
Pageof 6